Aktis Oncology, Inc.
Institutional holders · 13F as of Jun 30, 2026
| Holder | Value | % of shares |
|---|---|---|
| BlackRock, Inc. | $73.43M | 4.12% |
| Merck & Co., Inc. | $30.71M | 1.72% |
| RA Capital Management, L.P. | $26.89M | 2.72% |
| JANUS HENDERSON GROUP PLC | $26.02M | 2.63% |
| Baker Bros. Advisors LP | $17.82M | 1.80% |
| STATE STREET CORPORATION | $15.60M | 0.88% |
| GEODE CAPITAL MANAGEMENT, LLC | $8.80M | 0.89% |
| TD ASSET MANAGEMENT INC | $1.81M | 0.18% |
| Laurion Capital Management LP | $1.79M | 0.18% |
| SOROS FUND MANAGEMENT LLC | $1.79M | 0.18% |
| Bank of New York Mellon Corp/The | $767.5K | 0.08% |
| DEUTSCHE BANK AG | $677.5K | 0.04% |
| RHUMBLINE ADVISERS | $376.3K | 0.04% |
| D. E. Shaw & Co., Inc. | $305.2K | 0.03% |
| The PNC Financial Services Group, Inc. | $197.9K | 0.01% |
| BNP PARIBAS FINANCIAL MARKETS | $80.1K | 0.01% |
| Pinnacle Wealth Planning Services, Inc. | $73.1K | 0.00% |
| Ameritas Investment Partners, Inc. | $30.1K | 0.00% |
| Sterling Capital Management LLC | $7.0K | 0.00% |
| SG Americas Securities, LLC | $109 | 0.01% |
| Covestor Ltd | $1 | 0.00% |